These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 16569791

  • 1. Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
    Ranjan S, Chandra PS, Chaturvedi SK, Prabhu SC, Gupta A.
    Ann Pharmacother; 2006 Apr; 40(4):771-4. PubMed ID: 16569791
    [Abstract] [Full Text] [Related]

  • 2. Role of mirtazapine in the treatment of antipsychotic-induced akathisia.
    Hieber R, Dellenbaugh T, Nelson LA.
    Ann Pharmacother; 2008 Jun; 42(6):841-6. PubMed ID: 18460588
    [Abstract] [Full Text] [Related]

  • 3. Mirtazapine for akathisia in bipolar disorder.
    Wilson MS.
    J Clin Psychopharmacol; 2005 Aug; 25(4):394-5. PubMed ID: 16012289
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
    Poyurovsky M, Epshtein S, Fuchs C, Schneidman M, Weizman R, Weizman A.
    J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
    [Abstract] [Full Text] [Related]

  • 5. Akathisia induced by mirtazapine after 20 years of continuous treatment.
    Markoula S, Konitsiotis S, Chatzistefanidis D, Lagos G, Kyritsis AP.
    Clin Neuropharmacol; 2010 Jun; 33(1):50-1. PubMed ID: 20124786
    [Abstract] [Full Text] [Related]

  • 6. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M, Pashinian A, Weizman R, Fuchs C, Weizman A.
    Biol Psychiatry; 2006 Jun 01; 59(11):1071-7. PubMed ID: 16497273
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia.
    Poyurovsky M, Bergman J, Pashinian A, Weizman A.
    Int Clin Psychopharmacol; 2014 Sep 01; 29(5):296-8. PubMed ID: 24667488
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C, Baghai TC, Eser D, Hecht S, Hermisson I, Born C, Häfner S, Nothdurfter C, Rupprecht R.
    World J Biol Psychiatry; 2007 Sep 01; 8(2):112-22. PubMed ID: 17455104
    [Abstract] [Full Text] [Related]

  • 9. Mirtazapine for neuroleptic-induced akathisia.
    Poyurovsky M, Weizman A.
    Am J Psychiatry; 2001 May 01; 158(5):819. PubMed ID: 11329417
    [No Abstract] [Full Text] [Related]

  • 10. Acute antipsychotic-induced akathisia revisited.
    Poyurovsky M.
    Br J Psychiatry; 2010 Feb 01; 196(2):89-91. PubMed ID: 20118449
    [Abstract] [Full Text] [Related]

  • 11. A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
    Zink M, Knopf U, Argiriou S, Kuwilsky A.
    J Clin Psychiatry; 2006 May 01; 67(5):835. PubMed ID: 16841636
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study.
    Poyurovsky M, Shardorodsky M, Fuchs C, Schneidman M, Weizman A.
    Br J Psychiatry; 1999 Mar 01; 174():238-42. PubMed ID: 10448449
    [Abstract] [Full Text] [Related]

  • 13. Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
    Loonen AJ, Doorschot CH, Oostelbos MC, Sitsen JM.
    Eur Neuropsychopharmacol; 1999 Dec 01; 10(1):51-7. PubMed ID: 10647097
    [Abstract] [Full Text] [Related]

  • 14. Treatment of Antipsychotic-Related Akathisia Revisited: The Role of Serotonin 2A Receptor Antagonists.
    Poyurovsky M, Weizman A.
    J Clin Psychopharmacol; 2015 Dec 01; 35(6):711-4. PubMed ID: 26488676
    [Abstract] [Full Text] [Related]

  • 15. Adverse events related to olanzapine.
    Conley RR, Meltzer HY.
    J Clin Psychiatry; 2000 Dec 01; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [Abstract] [Full Text] [Related]

  • 16. Serotonergic agents in the treatment of acute neuroleptic-induced akathisia: open-label study of buspirone and mianserin.
    Poyurovsky M, Weizman A.
    Int Clin Psychopharmacol; 1997 Sep 01; 12(5):263-8. PubMed ID: 9466160
    [Abstract] [Full Text] [Related]

  • 17. Very Low-Dose Mirtazapine (7.5 mg) in Treatment of Acute Antipsychotic-Associated Akathisia.
    Poyurovsky M, Weizman A.
    J Clin Psychopharmacol; 2018 Dec 01; 38(6):609-611. PubMed ID: 30300293
    [Abstract] [Full Text] [Related]

  • 18. Mirtazapine-induced akathisia.
    Gulsun M, Doruk A.
    J Clin Psychopharmacol; 2008 Aug 01; 28(4):467. PubMed ID: 18626283
    [No Abstract] [Full Text] [Related]

  • 19. Chronic restlessness with antipsychotics.
    Bratti IM, Kane JM, Marder SR.
    Am J Psychiatry; 2007 Nov 01; 164(11):1648-54. PubMed ID: 17974927
    [No Abstract] [Full Text] [Related]

  • 20. The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex.
    Kamińska K, Gołembiowska K, Rogóż Z.
    Pharmacol Rep; 2014 Dec 01; 66(6):984-90. PubMed ID: 25443725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.